ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Bio Rad Laboratories Inc

Bio Rad Laboratories Inc (BIO.B)

279.91
0.00
(0.00%)
Closed May 01 4:00PM
0.00
0.00
(0.00%)
After Hours: 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
279.91
Bid
-
Ask
-
Volume
75
270.75 Day's Range 274.32
268.80 52 Week Range 467.95
Market Cap
Previous Close
279.91
Open
274.32
Last Trade
2
@
278.55
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
326
Shares Outstanding
28,518,436
Dividend Yield
-
PE Ratio
-12.53
Earnings Per Share (EPS)
-22.35
Revenue
2.67B
Net Profit
-637.32M

About Bio Rad Laboratories Inc

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for c... Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Bio Rad Laboratories Inc is listed in the Lab Analytical Instruments sector of the New York Stock Exchange with ticker BIO.B. The last closing price for Bio Rad Laboratories was $279.91. Over the last year, Bio Rad Laboratories shares have traded in a share price range of $ 268.80 to $ 467.95.

Bio Rad Laboratories currently has 28,518,436 shares outstanding. The market capitalization of Bio Rad Laboratories is $7.98 billion. Bio Rad Laboratories has a price to earnings ratio (PE ratio) of -12.53.

BIO.B Latest News

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on...

Bio-Rad’s Chief Operating Officer Andrew Last to Retire

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100279.91279.91268.831279.91CS
4-54.17-16.2146791188334.08342.68268.898313.9219209CS
12-43.74-13.514599104323.65357.67268.8326333.51736295CS
268.523.13939349276271.39357.67268.8208327.86069082CS
52-179.11-39.0200862708459.02467.95268.8131338.30357765CS
156-351.94-55.6999287806631.85879268.8110502.18810745CS
260-31.65-10.1585569393311.56879268.8155461.63113763CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTMXCytomX Therapeutics Inc
$ 5.14
(215.34%)
206.72M
SYTSYLA Technologies Company Ltd
$ 3.375
(131.16%)
12.12M
RGFReal Good Food Company Inc
$ 0.49
(72.78%)
4.67M
BCABBioAtla Inc
$ 3.39
(50.33%)
4.1M
PBMPsyence Biomedical Ltd
$ 1.2099
(34.52%)
5.86M
CETXCemtrex Inc
$ 0.3055
(-73.20%)
18.61M
BENFBeneficient
$ 2.041
(-38.52%)
292.68k
CVRXCVRx Inc
$ 10.075
(-35.04%)
1.58M
CRMLCritical Metals Corporation
$ 7.96
(-24.19%)
27k
CGCCanopy Growth Corporation
$ 11.4352
(-23.15%)
55.26M
SQQQProShares UltraPro Short QQQ
$ 12.22
(2.26%)
210.88M
CTMXCytomX Therapeutics Inc
$ 5.14
(215.34%)
206.72M
AKANAkanda Corporation
$ 0.1149
(23.55%)
181.14M
TQQQProShares UltraPro QQQ
$ 51.60
(-2.15%)
104.3M
AMZNAmazon.com Inc
$ 179.00
(2.29%)
95.02M

Discussion

View Full Feed
cjstocksup cjstocksup 3 minutes ago
https://x.com/RealJamesWoods/status/1785541406905582060
trademax42 trademax42 3 minutes ago
Speak for yourself. If you're not happy with the way things are happening here, just move along and be happy somewhere. This makes sense to me.

Don't respond I'm done with this nonsense.
AGBA
bentleyt bentleyt 4 minutes ago
We are way overdue for something positive
CRXM
muee88 muee88 4 minutes ago
I was simply updating that it still had not been filed as flipper indicated it may take some time for it to be picked up by court listener, and because I have access to Pacer.
NWBO
cjstocksup cjstocksup 4 minutes ago
https://x.com/RealJamesWoods/status/1785542849460850912
cjstocksup cjstocksup 4 minutes ago
https://x.com/RealJamesWoods/status/1785542849460850912
janice shell janice shell 4 minutes ago
LOLOLOLOL!!
WeTheMarket WeTheMarket 4 minutes ago
Advent Technologies Holdings Approves Reverse Stock Split
May 01 2024
https://ih.advfn.com/stock-market/NASDAQ/advent-technologies-ADN/stock-news/93760545/advent-technologies-holdings-approves-reverse-stoc
ADN
janice shell janice shell 4 minutes ago
Thank you! But what about "eschew"?
tbirdman tbirdman 5 minutes ago
Lol
CNEY
cjstocksup cjstocksup 5 minutes ago
https://x.com/RealJamesWoods/status/1785547661153796130
TRAPPER JIM TRAPPER JIM 6 minutes ago
RSPI keeps getting out there with the big boys.
RSPI
Hercules1 Hercules1 6 minutes ago
You need to move on to a stock you like.

This stock is not your cup of tea evidently.

Take your weeping and whining elsewhere.

We don’t quite care much for cowards.


AGBA
biosectinvestor biosectinvestor 6 minutes ago
Oh nonsense. They are all over the place as the microcap level. They are constantly being shorted and attacked by opportunists who think they can take them over like Martin Shkreli. And some have garbage and stay valued highly for years before they crash, because they are being milked by investme
CDMO
tdbowieknife tdbowieknife 6 minutes ago
Lol... DeadHawk still a revoked, worthless, dead scam.

..


.



.
cjstocksup cjstocksup 6 minutes ago
https://x.com/RealJamesWoods/status/1785550120714645653
JohnnyHydrogen JohnnyHydrogen 7 minutes ago
Exxon and FCEL have both repeatedly stated for years that CCS was possible at 90% rate.

So why not 90% in Rotterdam?

Makes no sense unless games/politics are in control.

https://corporate.exxonmobil.com/what-we-do/delivering-industrial-solutions/carbon-
FCEL
TRAPPER JIM TRAPPER JIM 7 minutes ago
Me and Mali have the whole house to ourselves. Kelly is in Nashville Tennessee for work until Friday evening. I took Mali to the high school softball game and then we went to watch Deklans practice. He came back home with us. We ate dinner and I took him home. Then went to the casino for a little bi
cadillacdave cadillacdave 8 minutes ago
Pension funds and money managers are told, in some cases, which stocks to push and others to avoid, and not because they are bad stocks.

Money, power and influence changes hands behind the scenes.

So the Dubster is not wrong in what he is saying.
NVDA
Dyno89 Dyno89 8 minutes ago
Well knowing his track record first hand from years in the other one, I don’t trust him one bit. But I hope for a change he’s being truthful in today’s tweet.
IGPK
cjstocksup cjstocksup 8 minutes ago
https://x.com/RealJamesWoods/status/1785550830533509149
cjstocksup cjstocksup 9 minutes ago
https://x.com/RealJamesWoods/status/1785562639202164790
biowin biowin 9 minutes ago
https://www.globenewswire.com/news-release/2024/05/01/2872958/0/en/Renewable-Chemicals-Market-To-Reach-USD-343-2-Billion-By-2032-Says-DataHorizzon-Research.html
Investor082 Investor082 10 minutes ago
Nothing changes our fortune outside a large non dilutive big pharma investment. JAMA, TLD, MIA all took us in the reverse direction. Even UK MHRA approvals upside will be short lived, if big pharma announcement doesn’t come shortly thereafter.
NWBO

Your Recent History

Delayed Upgrade Clock